Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

153
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
153
Cancer Therapies02:49

Cancer Therapies

7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Current Trends in Nursing II01:30

Current Trends in Nursing II

1.3K
Trends in nursing are multifactorial and associated with changes in society, within the nursing profession, and in other professions. Notably, telehealth and remote nursing contribute to successful healthcare delivery for numerous patients and help reduce stress for nurses due to nursing shortages. Nurses can reach patients, monitor their conditions, and interact with them using computers, audio, visual accessories, and telephones—for example, remote patient monitoring systems. Likewise,...
1.3K
Cancer Survival Analysis01:21

Cancer Survival Analysis

407
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
407
Biological Effects of Radiation02:59

Biological Effects of Radiation

15.7K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
15.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Oncologist and NHS Commissioner Perspectives on Reirradiation for Recurrent Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Patient Perspectives on Reirradiation for Recurrent Cancer, to Inform Future Clinical Trial Design.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Radiotherapy for Oesophageal Cancer in the United Kingdom: Patterns of Practice and Quality Indicators.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Developing an evidence base to inform retirement home policy development using an equity and diversity lens: a mixed methods study protocol.

BMC geriatrics·2025
Same author

Tackle Height and Tackle Success-An Analysis of 52,204 Tackle Events.

European journal of sport science·2025
Same author

Perspectives on Academic Training in Clinical Oncology in the United Kingdom: A National Cross-Sectional Analysis.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024

Related Experiment Video

Updated: Aug 6, 2025

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.2K

Health Services Research in Brachytherapy: Current Understanding and Future Challenges.

N Defourny1, P Mackenzie2, K Spencer3

  • 1Division of Cancer Sciences, University of Manchester, Manchester Cancer Research Centre, Manchester Academic Health Science Centre, Manchester, UK.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|March 20, 2023
PubMed
Summary

Greater brachytherapy availability is needed, but research on its use and cost-effectiveness lags. More studies are required to define optimal utilization and justify investment in this vital cancer treatment.

Keywords:
Accessbrachytherapycost-effectivenesscosting evaluationhealth service research

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.4K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.3K

Related Experiment Videos

Last Updated: Aug 6, 2025

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.2K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.4K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.3K

Area of Science:

  • Oncology
  • Health Services Research
  • Radiotherapy

Background:

  • Brachytherapy is crucial for cancer care, but its availability is a concern.
  • Health services research in brachytherapy lags behind other radiotherapy methods.
  • Optimal brachytherapy utilization and cost-effectiveness data are lacking globally.

Purpose of the Study:

  • To review current brachytherapy utilization research.
  • To highlight the need for further health services research in brachytherapy.
  • To inform future investment and service planning for brachytherapy.

Main Methods:

  • Literature review of brachytherapy utilization and health services research.
  • Analysis of existing data on brachytherapy use and cost-effectiveness.
  • Identification of research gaps in brachytherapy service delivery.

Main Results:

  • Limited studies report observed brachytherapy utilization rates.
  • Optimal utilization has not been defined beyond specific regions.
  • Robust cost and cost-effectiveness studies are scarce.

Conclusions:

  • There is an urgent need to increase brachytherapy availability and research.
  • Further studies are required to define optimal utilization and cost-effectiveness.
  • Evidence-based decision-making for brachytherapy investment is currently challenging.